These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 465874)

  • 1. Relationship between accumulation, storage and overflow of noradrenaline in the rat salivary gland after chronic treatment with guanethidine.
    Khan MT; Wakade AR
    Br J Pharmacol; 1979 Jun; 66(2):223-8. PubMed ID: 465874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bretylium and guanethidine on 3H-noradrenaline and 3H-serotonin release in rat brain cortex slices.
    Schlicker E; Göthert M
    Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):196-204. PubMed ID: 6220681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of surgical sympathectomy and of neonatal treatment with 6-hydroxydopamine and guanethidine on particle-bound noradrenaline and 35S-sulphomucopolysaccharides.
    Blaschke E; Uvnäs B
    Acta Physiol Scand; 1979 Jun; 106(2):159-67. PubMed ID: 159599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of stimulation of the sympathetic trunk on liberation of noradrenaline 3H into the rat blood stream: influence of guanethidine, phenoxybenzamine, cocaine and desipramine in vivo].
    Jacquot C; Bralet J; Cohen Y; Valette G
    Arch Int Pharmacodyn Ther; 1970 Oct; 187(2):245-64. PubMed ID: 5481480
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between the overflow of endogenous and radiolabelled noradrenaline from canine blood perfused gracilis muscle.
    Kahan T; Hjemdahl P; Dahlöf C
    Acta Physiol Scand; 1984 Dec; 122(4):571-82. PubMed ID: 6098140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of noradrenaline incorporation by nerve activities in the rat submaxillary gland.
    Chang CC; Chiueh CC
    J Physiol; 1969 Jul; 203(1):145-57. PubMed ID: 5821866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the sympathomimetic action of guanethidine on the isolated anococcygeus muscle of the rat.
    Foster RW; Shah DS; Small RC
    Br J Pharmacol; 1978 Feb; 62(2):307-13. PubMed ID: 623942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A correlation between inhibition of the uptake of 3H from (+)-3H-noradrenaline and potentiation of the responses to (-)-noradrenaline in the guinea-pig isolated trachea.
    Foster RW
    Br J Pharmacol Chemother; 1968 Jun; 33(2):357-67. PubMed ID: 5664154
    [No Abstract]   [Full Text] [Related]  

  • 9. Submaxillary secretion in rats treated with guanethidine.
    Eccher S; Dodson C; Quissell DO; Martinez JR
    Eur J Pharmacol; 1977 Jan; 41(2):113-21. PubMed ID: 832670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. POTENTIATION OF SOME CATECHOL AMINES BY PHENOXYBENZAMINE, GUANETHIDINE AND COCAINE.
    STAFFORD A
    Br J Pharmacol Chemother; 1963 Oct; 21(2):361-7. PubMed ID: 14081666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cocaine, phenoxybenzamine and calcium on the inhibition of norepinephrine output from the cat spleen by guanthidine.
    Kirpekar SM; Wakade AR; Dixon W; Prat JC
    J Pharmacol Exp Ther; 1969 Feb; 165(2):166-75. PubMed ID: 5763053
    [No Abstract]   [Full Text] [Related]  

  • 12. Antagonism by propranolol of the inhibitory effect of phenoxybenzamine on noradrenaline uptake in vivo.
    Chang CC; Wang WH
    J Pharm Pharmacol; 1971 Dec; 23(12):911-7. PubMed ID: 4402015
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of flow-stop on noradrenaline release from normal spleens and spleens treated with cocaine, phentolamine or phenoxybenzamine.
    Kirpekar SM; Puig M
    Br J Pharmacol; 1971 Oct; 43(2):359-69. PubMed ID: 4333804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of K(ATP) channel blockers on [(3)H]-noradrenaline overflow after short- and long-term exposure to (+)-oxaprotiline or desipramine.
    Eckhardt K; Roth P; Günter T; Schmidt S; Feuerstein TJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):168-75. PubMed ID: 12595958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence for the purinergic inhibition of adrenergic neurotransmission in the rat portal vein.
    Enero MA
    Acta Physiol Lat Am; 1981; 31(2):93-103. PubMed ID: 6316732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between guanethidine and inhibitors of noradrenaline uptake.
    Hanahoe TH; Ireson JD; Large BJ
    Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):349-53. PubMed ID: 5371186
    [No Abstract]   [Full Text] [Related]  

  • 17. Depletion of cardiac noradrenaline stores by the calcium-channel blocker D-600.
    Chaudhry A; Vohra MM
    Can J Physiol Pharmacol; 1984 Jun; 62(6):640-4. PubMed ID: 6744107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of sympathetic noradrenergic transmission by guanabenz and guanethidine in rat isolated mesenteric artery: involvement of neuronal potassium channels.
    Fabiani ME; Story DF
    Pharmacol Res; 1996 Mar; 33(3):171-80. PubMed ID: 8880888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The influence of treatment with cocaine on the synthesis and liberation of cerebral noradrenaline].
    Bralet J; Lallemant AM
    Arch Int Pharmacodyn Ther; 1975 Oct; 217(2):332-41. PubMed ID: 1190926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of noradrenaline release by adenosine.
    Wakade AR; Wakade TD
    J Physiol; 1978 Sep; 282():35-49. PubMed ID: 722535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.